[1] BASHIARDES S,SHAPIRO H,ROZIN S,et al.Non-alcoholic fatty liver and the gut microbiota[J].Molecular Metabolism,2016,5(9):782.
[2] ABENAVOLI L,MILIC N,DI RENZO L,et al.Metabolic aspects of adult patients with nonalcoholic fatty liver disease[J].World J Gastroenterol,2016,22(31):7006.
[3] ZHU JZ,HOLLIS-HANSEN K,WAN XY,et al.Clinical guidelines of non-alcoholic fatty liver disease:a systematic review[J].World J Gastroenterol,2016,22(36):8226.
[4] HSU WF,SHEEN LY,LIN HJ,et al.A review of western and traditional chinese medical approaches to managing nonalcoholic fatty liver disease[J].Evid Based Complement Alternat Med,2016,2016(9):6491420.
[5] WANG XL,LIU ZP,WANG K,et al.Additive effects of the risk alleles of PNPLA3 and TM6SF2 on nonalcoholic fatty liver disease(NAFLD) in a Chinese population[J].Front Genet,2016,7:140.
[6] KÖROǦLU E,CANBAKAN B,ATAY K,et al.Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease[J].Turk J Gastroenterol,2016,27(4):361.
[7] WANG X,LIU Z,WANG K,et al.An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis[J].PLoS One,2016,11(7):e0158817.
[8] MARCHESINI G,BUGIANESI E,FORLANI G,et al.Nonalcoholic fatty liver,steatohepatitis,and the metabolic syndrome[J].Hepatology,2003,37(4):917.
[9] YU J,MARSH S,HU J,et al.The pathogenesis of nonalcoholic fatty liver disease:interplay between diet,gut microbiota,and genetic background[J].Gastroenterol Res Pract,2016(2016):ID2862173.
[10] 葛麟,谭正怀,唐大轩,等.轻肝颗粒对小鼠非酒精性脂肪肝的作用研究[J].中药药理与临床,2009,25(2):94.
[11] 南月敏,王蕾,李良宵,等.非酒精性脂肪肝动物模型研究进展[J].河北医科大学学报,2007,28(1):67.
[12] 吴利春,尹梦,候梦莹,等.高脂联合地塞米松诱导小鼠急性脂肪肝模型的实验研究[J].重庆医学,2017(17):2383.
[13] 潘磊,张金彪,崔荣岗,等.非酒精性脂肪肝C57BL/6小鼠模型的建立[J].中国组织工程研究,2016,20(40):6054.